NDC 0173-0859-14
Breo Ellipta 100 ug/1
fluticasone furoate and vilanterol trifenatate · POWDER
Breo Ellipta is a powder containing fluticasone furoate and vilanterol trifenatate at a strength of 100 ug/1. Manufactured by GlaxoSmithKline LLC.
Key Facts
- Brand Name
- Breo Ellipta
- Generic Name
- fluticasone furoate and vilanterol trifenatate
- NDC Code (Package)
0173-0859-14- NDC Code (Product)
0173-0859- Manufacturer
- GlaxoSmithKline LLC
- Strength
- 100 ug/1
- Dosage Form
- POWDER
- Route
- RESPIRATORY (INHALATION)
- Marketing Status
- Application #
- NDA204275
- Marketing Start
- 08/26/2013
Recall History
No Recall HistoryView Full Drug Page
Breo Ellipta — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.